| Transaction Date | Filer | Title | Filing | Transaction Type | Shares Traded | Price | Total Held* |
|---|---|---|---|---|---|---|---|
| May 20, 2020 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 499 | $320.40 | 17,435 | |
| May 20, 2020 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 499 | $320.40 | 28,363 | |
| May 20, 2020 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 499 | $320.40 | 8,845 | |
| May 20, 2020 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 499 | $320.40 | 13,244 | |
| May 20, 2020 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 499 | $320.40 | 3,948 | |
| May 20, 2020 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 499 | $320.40 | 2,470 | |
| May 05, 2020 | CVP & Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 8,753 | -- | 8,753 | |
| May 05, 2020 | CVP & Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 3,847 | -- | 3,847 | |
| Mar 31, 2020 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 107 | $302.55 | 5,494 | |
| Mar 31, 2020 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 136 | $302.55 | 36,751 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.